Advertisement

Pediatric Drugs

, Volume 5, Issue 8, pp 505–511 | Cite as

Pediatric Molluscum Contagiosum

Optimal Treatment Strategies
  • Nanette B. SilverbergEmail author
Current Opinion

Abstract

Pediatric molluscum contagiosum virus (MCV) is a common pox viridae infection that represents a common public health issue. The spread of the virus among children is rapid and easy. The virus produces a number of substances that block immune response formation in the infected host. Despite the benign and self-limited nature of the condition, one-third of children have symptoms from, or secondary reactions to the infection, including pruritus, erythema and, occasionally, inflammation and pain. Patients with pruritis autoinoculate the virus through scratching, thereby exacerbating their conditions.

While adults cope well with unanesthetized curettage of lesions, children require less painful therapeutic options. The options for therapy are manifold. Therapy should begin with gentle skin care and antipruritics to prevent symptoms, and to prevent the spread of the disease. Therapies with good efficacy and low risk of pain for the patient include in-office usage of cantharidin and the use of local anesthetics, such as topical lidocaine (lignocaine) preparations in combination with the curettage of visible lesions. Alternatively, cryosurgery can be performed to eradicate lesions in-office. At-home therapeutics are often preferred by parents and children, and include imiquimod, retinoids, and α-hydroxy acids. Although a variety of such at-home therapies are available, none are as effective or as rapid acting as in-office therapy.

Further research in large clinical trials is required to increase knowledge on prevention, optimal treatment, and long-term outcome with this disease.

Keywords

Atopic Dermatitis Tretinoin Imiquimod Condyloma Acuminatum Glycolic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors have provided no information on sources of funding or on conflicts of interest directly relevant to the content of this review.

References

  1. 1.
    Diven DG. An overview of poxviruses. J Am Acad Dermatol 2001; 44: 1–16PubMedCrossRefGoogle Scholar
  2. 2.
    Douglas JD, Tanner KN, Prine JR, et al. Molluscum contagiosum in chimpanzees. J Am Vet Med Assoc 1967; 151: 901–4PubMedGoogle Scholar
  3. 3.
    Bagnall BG, Wilson GR. Molluscum contagiosum in a red kangaroo. Australas J Dermatol 1974; 15: 115–20PubMedCrossRefGoogle Scholar
  4. 4.
    Porter CD, Archard LC. Characterization by restriction mapping of three subtypes of molluscum contagiosum virus. J Med Virol 1992; 38: 1–6PubMedCrossRefGoogle Scholar
  5. 5.
    Thompson CH. Immunoreactive proteins of molluscum contagiosum virus types l,1v, and 2. J Infect Dis 1998; 178: 1230–1PubMedCrossRefGoogle Scholar
  6. 6.
    Becker TM, Blount JH, Douglas J, et al. Trends in molluscum contagiosum in the United States, 1966–1983. Sex Transm Dis 1986; 13: 88–92PubMedCrossRefGoogle Scholar
  7. 7.
    Cotton DWK, Cooper C, Barrett DF, et al. Severe atypical molluscum contagiosum infection in an immunocompromised host. Br J Dermatol 1987; 116: 871–6PubMedCrossRefGoogle Scholar
  8. 8.
    Epstein WL. Molluscum contagiosum. Semin Dermatol 1992; 11: 184–9PubMedGoogle Scholar
  9. 9.
    Vander Straten M, Tyring SK. Mucocutaneous manifestations of viral diseases in children. Clin Dermatol 2002; 20: 67–73CrossRefGoogle Scholar
  10. 10.
    Oriel JD. The increase in molluscum contagiosum. Br Med J (Clin Res Ed) 1987; 294: 74CrossRefGoogle Scholar
  11. 11.
    Watanabe T, Nakamura K, Wakugawa M, et al. Antibodies to molluscum contagiosum virus in the general population and susceptible patients. Arch Dermatol 2000; 136: 1518–22PubMedCrossRefGoogle Scholar
  12. 12.
    Xiang Y, Moss B. Identification of human and mouse homologs of the MC51L-53L-54L family of secreted glycoproteins encoded by the molluscum contagiosum poxvirus. Virology 1999; 257: 297–302PubMedCrossRefGoogle Scholar
  13. 13.
    Xiang Y, Moss B. Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins. J Virol 2001; 75: 9947–54PubMedCrossRefGoogle Scholar
  14. 14.
    Luttichau HR, Lewis IC, Gerstoft J, et al. The herpes virus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor. Eur J Immunol 2001; 31: 1217–20PubMedCrossRefGoogle Scholar
  15. 15.
    Chen N, Baudino T, MacDonald PN, et al. Selective inhibition of nuclear steroid receptor function by a protein from a human tumorigenic poxvirus. Virology 2000; 274: 17–25PubMedCrossRefGoogle Scholar
  16. 16.
    Garvey TL, Bertin J, Siegel RM, et al. Binding of FADD and caspase-8 to molluscum contagiosum virus MC159 v-FLIP is not sufficient for its antiapoptotic function. J Virol 2002; 76: 79–84CrossRefGoogle Scholar
  17. 17.
    Smith KJ, Yeager J, Skelton H. Molluscum contagiosum: its clinical, histopathologic, and immunohistochemical spectrum. Int J Dermatol 1999; 38: 664–72PubMedCrossRefGoogle Scholar
  18. 18.
    Senkevich TG, Bugert JJ, Sisler JR, et al. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science 1996; 273: 813–6PubMedCrossRefGoogle Scholar
  19. 19.
    Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol 2000; 43: 503–7PubMedCrossRefGoogle Scholar
  20. 20.
    Niizeki K, Kano O, Kondo Y. An epidemic study of molluscum contagiosum: relationship to swimming. Dermatologica 1984; 169: 197–8PubMedCrossRefGoogle Scholar
  21. 21.
    Laughter D, Istvan JA, Tofte SJ, et al. The prevalence of atopic dermatitis in Oregon school children. J Am Acad Dermatol 2000 Oct; 43(4): 649–55PubMedCrossRefGoogle Scholar
  22. 22.
    Choong KY, Roberts LJ. Molluscum contagiosum, swimming and bathing: a clinical analysis. Australas J Dermatol 1999; 40: 89–92PubMedCrossRefGoogle Scholar
  23. 23.
    Oren B, Wende SO. An outbreak of molluscum contagiosum in a kibbutz. Infection 1991; 19: 159–61PubMedCrossRefGoogle Scholar
  24. 24.
    DeOre GA, Johnson HH, Binkley GW. An eczematous reaction associated with molluscum contagious. Arch Dermatol 1956; 74: 344–8CrossRefGoogle Scholar
  25. 25.
    Fornatora ML, Reich RF, Gray RG, et al. Intraoral molluscum contagiosum: a report of a case and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 318–20PubMedCrossRefGoogle Scholar
  26. 26.
    Rao VA, Baskaran RK, Krishnan MM. Unusual cases of molluscum contagiosum of eye. Indian J Ophthalmol 1985 Jul-Aug; 33(4): 263–5PubMedGoogle Scholar
  27. 27.
    Brandrup F, Asschenfeldt P. Molluscum contagiosum-induced comedo and secondary abscess formation. Pediatr Dermatol 1989; 6: 118–21PubMedCrossRefGoogle Scholar
  28. 28.
    Ive FA. Follicular molluscum contagiosum. Br J Dermatol 1985; 113: 493–5PubMedCrossRefGoogle Scholar
  29. 29.
    Ha SJ, Park YM, Cho SH, et al. Solitary giant molluscum contagiosum of the sole. Pediatr Dermatol 1998; 15: 222–4PubMedCrossRefGoogle Scholar
  30. 30.
    Benton EC. Human papillomavirus infection and molluscum contagiosum. In Harper J, Oranje A, Prose N, editors. Textbook of pediatric dermatology. Oxford: Blackwell Science, 2000: 320Google Scholar
  31. 31.
    Hurwitz S. Molluscum contagiosum. In: Hurwitz S, editor. Clinical pediatric dermatology. 2nd ed. Philadelphia (PA): WB Saunders Company, 1993: 339–40Google Scholar
  32. 32.
    Hellier FF. Profuse mollusca contagiosa of the face induced by corticosteroids. Br J Dermatol 1971; 85: 398PubMedCrossRefGoogle Scholar
  33. 33.
    Cribier B, Scrivener Y, Grosshans E. Molluscum contagiosum: histologic patterns and associated lesions: a study of 578 cases. Am J Dermatopathol 2001; 23: 99–103PubMedCrossRefGoogle Scholar
  34. 34.
    Rocamora V, Romani J, Puig L, et al. Id reaction to molluscum contagiosum. Pediatr Dermatol 1996; 13: 349–50PubMedCrossRefGoogle Scholar
  35. 35.
    Weller R, O’Callaghan CJ, MacSween RM, et al. Scarring in molluscum contagiosum: comparison of physical expression and phenol ablation. BMJ 1999 Dec 11; 319: 1540PubMedCrossRefGoogle Scholar
  36. 36.
    Thomas III JR, Doyle JA. The therapeutic uses of topical vitamin A acid. J Am Acad Dermatol 1981; 4: 505–13PubMedCrossRefGoogle Scholar
  37. 37.
    Papa CM, Berger RS. Venereal herpes-like molluscum contagiosum: treatment with tretinoin. Cutis 1976; 18: 537–40PubMedGoogle Scholar
  38. 38.
    Garrett SJ, Robinson JK, Roenigk HH. Trichloroacetic acid peel of molluscum contagiosum in immunocompromised patients. J Dermatol Surg Oncol 1992; 18: 855–8PubMedGoogle Scholar
  39. 39.
    Ohuma M. Molluscum contagiosum treated with iodine solution and salicylic acid plaster. Int J Dermatol 1990 Jul-Aug; 29(6): 443–5CrossRefGoogle Scholar
  40. 40.
    Trizna Z. Viral diseases of the skin: diagnosis and antiviral treatment. Paediatr Drugs 2002; 4: 9–19PubMedGoogle Scholar
  41. 41.
    Barba AR, Kapoor S, Berman B. An open label safety study of topical imiquimod 5% cream in the treatment of molluscum contagiosum in children. Dermatol Online J 2001 Feb; 7(1): 20PubMedGoogle Scholar
  42. 42.
    Tyring S. Imiquimod applied topically: a novel immune response modifier. Skin Therapy Lett 2001 Mar; 6(6): 1–4Google Scholar
  43. 43.
    Liota E, Smith KJ, Buckley R, et al. Imiquimod therapy for molluscum contagiosum. J Cutan Med Surg 2000; 4: 76–82PubMedGoogle Scholar
  44. 44.
    Skinner Jr RB, Ray S, Talanin NY. Treatment of molluscum contagiosum with topical 5% imiquimod cream [letter]. Pediatr Dermatol 2000; 17: 420PubMedCrossRefGoogle Scholar
  45. 45.
    Hengge UR, Esser S, Schultewolter T, et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000 Nov; 143: 1026–31PubMedCrossRefGoogle Scholar
  46. 46.
    Edwards L. Imiquimod in clinical practice. J Am Acad Dermatol 2000; 43: S12–7PubMedCrossRefGoogle Scholar
  47. 47.
    Syed TA, Goswami J, Ahmadpour OA, et al. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. J Dermatol 1998; 25: 309–13PubMedGoogle Scholar
  48. 48.
    Dohil M, Prendiville JS. Treatment of molluscum contagiosum with oral cimetidine: clinical experience in 13 patients. Pediatr Dermatol 1996; 13: 310–2PubMedCrossRefGoogle Scholar
  49. 49.
    Romiti R, Ribeiro AP, Romiti N. Evaluation of the effectiveness of 5% potassium hydroxide for the treatment of molluscum contagiosum [letter]. Pediatr Dermatol 2000; 17: 495PubMedCrossRefGoogle Scholar
  50. 50.
    Romiti R, Ribeiro AP, Grinblat BM, et al. Treatment of molluscum contagiosum with potassium hydroxide: a clinical approach in 35 children. Pediatr Dermatol 1999; 16: 228–31PubMedCrossRefGoogle Scholar
  51. 51.
    Toro JR, Wood LV, Patel NK, et al. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. Arch Dermatol 2000; 136: 983–5PubMedCrossRefGoogle Scholar
  52. 52.
    Calista D. Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS: a pilot study. J Eur Acad Dermatol Venereol 2000; 14: 484–8PubMedCrossRefGoogle Scholar
  53. 53.
    Hurni MA, Bohlen L, Furrer H, et al. Complete regression of giant molluscum contagiosum lesions in an HIV-infected patient following combined anti-retroviral therapy with saquinavir, zidovudine and lamivudine. AIDS 1997; 11: 1784–5PubMedGoogle Scholar
  54. 54.
    Calista D, Morri M, Stagno A, et al. Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor. Am J Clin Dermatol 2002; 3: 59–62PubMedCrossRefGoogle Scholar
  55. 55.
    Silverberg NB. Garlic cloves for verruca vulgaris [letter]. Pediatr Dermatol 2002; 19(2): 183PubMedCrossRefGoogle Scholar
  56. 56.
    Rosdahl I, Edmar B, Gisslen H, et al. Curettage of molluscum contagiosum in children: analgesia by topical application of a lidocaine/prilocaine cream (EM-LA). Acta Derm Venereol 1988; 18: 149–53Google Scholar
  57. 57.
    de Waard-van der Spek FB, Oranje AP, Lillieborg S, et al. Treatment of molluscum contagiosum using a lidocaine/prilocaine cream (EMLA) for analgesia. J Am Acad Dermatol 1990; 23: 685–8PubMedCrossRefGoogle Scholar
  58. 58.
    Ronnerfalt L, Fransson J, Wahlgren CF. EMLA cream provides rapid pain relief for the curettage of molluscum contagiosum in children with atopic dermatitis without causing serious application-site reactions. Pediatr Dermatol 1998; 15: 309–12PubMedCrossRefGoogle Scholar
  59. 59.
    Moed L, Shwayder TA, Chang MW. Cantharidin revisited: a blistering defense of an ancient medicine. Arch Dermatol 2001; 137: 1357–60PubMedGoogle Scholar
  60. 60.
    Kuflik EG. Cryosurgery updated. J Am Acad Dermatol 1994; 37: 82–4CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Authors and Affiliations

  1. 1.Pediatric DermatologySt. Luke’s-Roosevelt Hospital Center, and Columbia College of Physicians and SurgeonsNew YorkUSA

Personalised recommendations